| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | WO2009074234A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | WO2009074065A1 Use of daphne primeverose genkwanine and daphne plants |
| 06/18/2009 | WO2009074020A1 Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof |
| 06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | WO2009073973A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | WO2009050567A3 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 06/18/2009 | WO2009046864A3 Use of the human pancreatic polypeptide as a therapeutic agent |
| 06/18/2009 | WO2009046847A3 Use of peptide ll-37 as a therapeutic agent |
| 06/18/2009 | WO2009046846A3 Use of il-1 receptor peptide, alone or in combination with peptide ll-37, as a therapeutic agent |
| 06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
| 06/18/2009 | WO2009043476A3 Neuromedin s as a therapeutic agent |
| 06/18/2009 | WO2009043448A3 Neuromedin u-25 and neuromedin s as therapeutic agents |
| 06/18/2009 | WO2009043440A3 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/18/2009 | WO2009037394A3 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 06/18/2009 | WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties |
| 06/18/2009 | WO2009025806A3 Use of vegfr-2 inhibitors for treating metastatic cancer |
| 06/18/2009 | WO2009016081A3 Benzoind0l-2-one derivatives for use in therapy |
| 06/18/2009 | WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 06/18/2009 | WO2008141107A8 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 06/18/2009 | WO2008122858A9 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 06/18/2009 | WO2008056266A8 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 06/18/2009 | WO2007144679A3 Compounds, kits and methods for conferring cytoprotection |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156794 Compositions and methods for activating genes of interest |
| 06/18/2009 | US20090156742 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 06/18/2009 | US20090156688 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 06/18/2009 | US20090156672 Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities |
| 06/18/2009 | US20090156659 System and method for collecting, storing, processing, transmitting and presenting very low amplitude signals |
| 06/18/2009 | US20090156641 Inhibition of cyclooxygenase-2 activity |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
| 06/18/2009 | US20090156627 Therapeutic compounds |
| 06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 06/18/2009 | US20090156617 Tyrosine kinase inhibitors |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156611 Mammalian hedgehog signaling modulators |
| 06/18/2009 | US20090156610 Spiroindolinone Derivatives |
| 06/18/2009 | US20090156604 Fused bicyclic imidazoles |
| 06/18/2009 | US20090156596 Unsaturated Heterocyclic Derivatives |
| 06/18/2009 | US20090156594 Heterocyclic kinase modulators |
| 06/18/2009 | US20090156584 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam |
| 06/18/2009 | US20090156559 2-{[2-(Diethylamino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidate; chemical intermediates; free of by-products acrolein; release "cyclophosphate mustards" and do not require metabolic activation; anticarcinogenic agents; antitumor agents; autoimmune diseases |
| 06/18/2009 | US20090156557 Kinase inhibitors |
| 06/18/2009 | US20090156548 Fluorocytidine derivatives and cox-2 inhibitors for the treatment of cancer |
| 06/18/2009 | US20090156547 1-(2,2-Difluoro-2-deoxy-b-D-ribofuranosyl)-4-(2-propyl-1-oxopentyl)amino-pyrimidin-2-one p-toluenesulfonic acid co-crystal; delivery by mouth;bioavailability; nontoxic; side effect reduction; hydrolysis to gemcitabinewith reduction of the formation of deoxydifluorouridine |
| 06/18/2009 | US20090156545 Substituted Phosphate Esters of Nucleoside Phosphonates |
| 06/18/2009 | US20090156541 for interfering with the DNA repair of double strand breaks (DSB); novel double-stranded nucleic acid molecules that act as baits and hijack the holocomplex of enzymes responsible of DNA DSB sensing, signaling and/or repair pathways |
| 06/18/2009 | US20090156528 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/18/2009 | US20090156522 Pancreatic Cancer Genes |
| 06/18/2009 | US20090156519 Modified KSA and Uses Thereof |
| 06/18/2009 | US20090156515 Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof |
| 06/18/2009 | US20090156513 freeze-dried fruit pulp powder; antioxidants comprises a high concentration of anthocyanin; treating disease or injury and damage induced by pathological free radicals; has a cyclooxygenase inhibition value greater than Aspirin; anticarcinogenic, antiinflammatory, antiarthritic agents; aging resistance |
| 06/18/2009 | US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 06/18/2009 | US20090156503 Cell penetrating peptides for intracellular delivery of molecules |
| 06/18/2009 | US20090156497 Non-cytotoxic PAP mutants |
| 06/18/2009 | US20090156475 Gene defects and mutant ALK kinase in human solid tumors |
| 06/18/2009 | US20090156469 Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating waldenstrom's macroglobulinemia |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 06/18/2009 | US20090155930 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155789 Genes from the 20q13 amplicon and their uses |
| 06/18/2009 | US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 |
| 06/18/2009 | US20090155398 Jucara and acai fruit-based dietary supplements |
| 06/18/2009 | US20090155354 Dispensing encapsulated liquids into body cavities |
| 06/18/2009 | US20090155344 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 06/18/2009 | US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases |
| 06/18/2009 | US20090155288 Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies |
| 06/18/2009 | US20090155287 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 06/18/2009 | US20090155284 Hgf-sf monoclonal antibody combinations |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155278 Claudins as Markers for Early Detection, Diagnosis, Prognosis and as Targets of Therapy for Breast and Metastatic Brain or Bone Cancer |
| 06/18/2009 | US20090155277 Use of immunesuppressant receptor |
| 06/18/2009 | US20090155268 Growth Factor Binding Constructs Materials and Methods |
| 06/18/2009 | US20090155265 Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies |
| 06/18/2009 | US20090155262 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 06/18/2009 | US20090155259 Extending time to disease progression or survival in cancer patients |
| 06/18/2009 | US20090155251 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/18/2009 | US20090155248 Antibodies to MT-SP1 serine protease |
| 06/18/2009 | US20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors |
| 06/18/2009 | US20090155244 Methods and compositions for poxvirus a35r protein |
| 06/18/2009 | US20090155231 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery |
| 06/18/2009 | US20090155229 Chondrocyte-based implant for the delivery of therapeutic agents |
| 06/18/2009 | US20090155224 Dimethyl amino ethyl ether psoralens and methods for their production and use |
| 06/18/2009 | US20090155218 Compositions and methods for growth of embryonic stem cells |
| 06/18/2009 | US20090155213 Lactobacillus acidophilus nucleic acids and uses thereof |
| 06/18/2009 | US20090155212 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155179 Kinetic biomarker for quantification of lymphoproliferation, clonal expansion, recruitment and trafficking in lymphoid tissues and of the in vivo actions of antigens and modulating thereon |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | US20090155164 Human c-fms antigen binding proteins |
| 06/18/2009 | DE102007060918A1 Verfahren zur Herstellung von cycloplatinierten Platin-Komplexen, durch dieses Verfahren hergestellte Platin-Komplexe sowie deren Verwendung A process for the production of cyclo platinized platinum complexes, platinum complexes prepared by this method and their use |
| 06/18/2009 | DE102007059752A1 Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone Functionalized solid polymer nanoparticles comprising epothilones |
| 06/18/2009 | DE102005009784B4 Peptid-Mimetika, Verfahren zur deren Herstellung, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung als Inhibitoren von Proteasomen und zur Induktion von Apoptose Peptide mimetics, methods for their preparation, pharmaceutical composition containing them and their use as inhibitors of proteasomes and inducing apoptosis |
| 06/18/2009 | CA2709209A1 Method for producing dendritic cells |
| 06/18/2009 | CA2709203A1 Hedgehog pathway antagonists and therapeutic applications thereof |